Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.5001
Delayed Data
As of 10:19am ET
 -0.0009 / -0.18%
Today’s Change
0.41
Today|||52-Week Range
2.24
-21.45%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.50
Today’s open0.50
Day’s range0.49 - 0.51
Volume247,547
Average volume (3 months)4,981,197
Market cap$239.8M
Dividend yield--
Data as of 10:19am ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.64%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...0.000.00%
OCULOcular Therapeutix I...-0.16-1.95%
PETXAratana Therapeutics...-0.09-1.37%
CMRXChimerix Inc-0.09-1.68%
Data as of 10:34am ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs